Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Bristol Myers Squibb Announced Aspire, A 10-year Strategy With An Aim To Reach Over 200,000 Patients In Low-And Middle-Income Countries By 2033, As Part Of Aspire, Bristol Myers Is Developing Tailored Strategies To Increase Affordability And Availability

Author: Benzinga Newsdesk | May 22, 2024 07:08am

Posted In: BMY